Clozapine efficacy in schizophrenic nonresponders
Conley, R.R.; Schulz, S.C.; Baker, R.W.; Collins, J.F.; Bell, J.A.
Psychopharmacology Bulletin 24(2): 269-274
1988
ISSN/ISBN: 0048-5764 PMID: 3212161 Document Number: 319074
Document emailed within 1 workday
Related Documents
Volavka, J. 1999: The effects of clozapine on aggression and substance abuse in schizophrenic patients Journal of Clinical Psychiatry 60(Suppl): 43-46Munn, N.A. 1993: Resolution of polydipsia and hyponatremia in schizophrenic patients after clozapine treatment Journal of Clinical Psychiatry 54(11): 439
Spivak, B.; Mester, R.; Abesgaus, J.; Wittenberg, N.; Adlersberg, S.; Gonen, N.; Weizman, A. 1997: Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients Journal of Clinical Psychiatry 58(7): 318-322
Kane, J.M. 1992: Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview British Journal of Psychiatry. Suppl 17: 41-45
Volpicelli, S.A.; Centorrino, F.; Puopolo, P.R.; Kando, J.; Frankenburg, F.R.; Baldessarini, R.J.; Flood, J.G. 1993: Determination of clozapine, norclozapine, and clozapine-N-oxide in serum by liquid chromatography Clinical Chemistry 39(8): 1656-1659
Sharif, Z.A.; Raza, A.; Ratakonda, S.S. 2000: Comparative efficacy of risperidone and clozapine in the treatment of patients with refractory schizophrenia or schizoaffective disorder: a retrospective analysis Journal of Clinical Psychiatry 61(7): 498-504
Werapongset, W.; Chaisirikul, S.; Chrujiporn, W.; Visanuyothin, T.; Kessawai, D.; Charisilp, C.; Ratanachata, N.; Sanichwannakul, K.; Wangdee, P.; Bunditchate, A.; Ukranand, P. 1998: Efficacy and tolerability of risperidone in chronic schizophrenic Thai patients Journal of the Medical Association of Thailand 81(5): 324-328
Høyeraal, H.M.; Fagertun, H.; Ingemann-Hansen, T.; Ersmark, H.; Rönn, O. 1993: Characterization of responders and nonresponders to tiaprofenic acid and naproxen in the treatment of patients with osteoarthritis Journal of Rheumatology 20(10): 1747-1752
Guy, W.; Cleary, P.; Bonato, R.R. 1970: The chronic schizophrenic as a research subject: Toxicity measures and their relationship to efficacy measures Psychopharmacology Bulletin 6(4): 34-58
Morozova, M.A.; Beniashvili, A.G.; Lepilkina, T.A.; Rupchev, G.E. 2012: Double-blind placebo-controlled randomized efficacy and safety trial of add-on treatment of dimebon plus risperidone in schizophrenic patients during transition from acute psychotic episode to remission Psychiatria Danubina 24(2): 159-166
Bralet, M.C.; Yon, V.; Loas, G.; Noisette, C. 2000: Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients L'Encephale 26(6): 32-41
Dev, V.J.; Rosenberg, T.; Krupp, P. 1994: Agranulocytosis and clozapine Bmj 309(6946): 54
Lurie, S.N. 1996: Combined use of ECT and clozapine Journal of Clinical Psychiatry 57(2): 94-95
Solomons, K.; Berman, K.G.; Gibson, B.A. 1998: All that seizes is not clozapine Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 43(3): 306-307
Steinbauer, G.; Diehl, L.W. 1980: Remarks on clozapine Der Nervenarzt 51(6): 373-374
Flynn, S.Willam. 2007: Clozapine interchangeability issues Journal of Clinical Psychiatry 68(8): 1310-1; Author Reply 1311
Zeng, Y.L.; Wang, Z.R.; Lu, M.L. 1986: Pharmacokinetics of clozapine in rabbits Yao Xue Xue Bao 21(8): 566-571
Patton, S.; Remick, R.A.; Isomura, T. 2000: Clozapine--an atypical reaction Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 45(4): 393-394
Kok, R.C.; Veenhoven, W.A.; Hoogschagen, M.J. 1992: Agranulocytosis caused by clozapine Nederlands Tijdschrift Voor Geneeskunde 136(16): 795-796
Mb, I.; Sharma, B. 2020: An unusual toxicity of clozapine Journal of the Association of Physicians of India 68(1): 105